Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-052855
Filing Date
2020-02-27
Accepted
2020-02-27 16:45:40
Documents
6
Effectiveness Date
2020-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 d897456ds8.htm S-8 75848
2 EX-5.1 d897456dex51.htm EX-5.1 9103
3 EX-23.2 d897456dex232.htm EX-23.2 1546
4 EX-23.3 d897456dex233.htm EX-23.3 1538
5 GRAPHIC g897456g0227075708716.jpg GRAPHIC 1649
6 GRAPHIC g897456img.jpg GRAPHIC 7360
  Complete submission text file 0001193125-20-052855.txt   101710
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236708 | Film No.: 20663034
SIC: 2834 Pharmaceutical Preparations